//
Clinical Research Associates LLC is a private association based in NEW YORK, NY. The foundation received its IRS ruling in 2015. The principal officer is % Marlow Kee. It holds total assets of $1.4M. Annual income is reported at $4.2M. EVALUATE NEW POTENTIAL THERAPIES FOR ASD, INCLUDING R-BACLOFEN, THROUGH ANIMAL AND HUMAN STUDIES, TO EXPLORE ITS POTENTIAL EFFICACY IN TREATING ASD-AFFECTED INDIVIDUALS. According to available records, Clinical Research Associates LLC has made 3 grants totaling $277K, with a median grant of $108K. Annual giving has decreased from $232K in 2020 to $45K in 2021. Individual grants have ranged from $45K to $125K, with an average award of $92K. The foundation has supported 2 unique organizations. Grants have been distributed to organizations in Washington and Pennsylvania. Contributions to this foundation are tax-deductible.
EVALUATE NEW POTENTIAL THERAPIES FOR ASD, INCLUDING R-BACLOFEN, THROUGH ANIMAL AND HUMAN STUDIES, TO EXPLORE ITS POTENTIAL EFFICACY IN TREATING ASD-AFFECTED INDIVIDUALS.
Expenses: $2.3M
EVALUATE NEW POTENTIAL THERAPIES FOR ASD, INCLUDING R-BACLOFEN, THROUGH ANIMAL AND HUMAN STUDIES, TO EXPLORE ITS POTENTIAL EFFICACY IN TREATING ASD-AFFECTED INDIVIDUALS. Based on available records, the foundation has funded 3 grants. Its grantmaking reaches organizations primarily in WA, PA.
Clinical Research Associates LLC has distributed a total of $277K across 3 grants. The median grant size is $108K, with an average of $92K. Individual grants have ranged from $45K to $125K.
Clinical Research Associates LLC typically selects its grantees rather than accepting unsolicited proposals.
Clinical Research Associates LLC is headquartered in NEW YORK, NY. While based in NY, the foundation distributes grants to organizations across 2 states.
| Name | Title | Compensation | Benefits | Total |
|---|---|---|---|---|
| Euan Robertson | MANAGER | $0 | $0 | $0 |
| Marlow Kee | TREASURER/MANAGER | $0 | $0 | $0 |
| Marion Greenup | SECRETARY | $0 | $0 | $0 |
| Kelsey Martin | PRESIDENT/MANAGER | $0 | $0 | $0 |
| David Spergel | CHAIRPERSON/MANAGER | $0 | $0 | $0 |
Total Giving
$3.8M
Total Assets
$1.4M
Fair Market Value
$1.4M
Net Worth
$759K
Grants Paid
$0
Contributions
$3.1M
Net Investment Income
$0
Distribution Amount
$0
Total Grants
3
Total Giving
$277K
Average Grant
$92K
Median Grant
$108K
Unique Recipients
2
Most Common Grant
$45K
of 2021 grantees were first-time recipients
| Recipient | Location | Amount | Year |
|---|---|---|---|
| University Of WashingtonELECTROPHYSIOLOGICAL INDICES OF NEURAL FUNCTION ASSOC. WITH ARBACLOFEN ADMIN. IN 16P11.2 | Seattle, WA | $45K | 2021 |
| The Children'S Hospital Of Philadelphia Research InstituteCOMPUTER VISION BASED PHENOTYPING OF 16P11.2 ARBACLOFEN DOUBLE BLIND PLACEBO CONTROLLED STUDY. | Philadelphia, PA | $108K | 2020 |
| 2018 | 990PF | View |
| 2017 | 990PF | View |
| 2015 | 990PF | View |
© 2026 Granted AI